A single centre experience of pembrolizumab combination therapy in untreated advanced non-squamous non-small-cell lung cancer (NSCLC)

Category Primary study
JournalLung Cancer
Year 2020
This article has no abstract
Epistemonikos ID: caacab2268d6622acf446ae71caf83cee6e52a66
First added on: Feb 11, 2025